MERIDITH MCELROY: Open Payments
NPI 1659067999 · MAYER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 18 payments from 8 companies in 2025. Trend: 2023 $217 · 2024 $563 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $175 |
| Indivior Inc. | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ABBVIE INC. | 2 | $34 |
| Exact Sciences Corporation | 1 | $29 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $20 |
| Braeburn Inc. | 1 | $16 |
Products named: FARXIGA, AIRSUPRA, SUBLOCADE, CAPLYTA, TRELEGY ELLIPTA, BREZTRI, The Cologuard Plus Collection Kit, ISTURISA.
Industry payments across AZ — which companies pay providers there.
